Recommendations to minimize diagnostic nuclear medicine exposure to the embryo, fetus, and infant; availability of final recommendations--FDA. Notice.
Food and Drug Administration (FDA) is announcing the availability of final recommendations to minimize diagnostic nuclear medicine exposure to the embryo, fetus, and breastfeeding infant. The final recommendations, prepared by FDA's Center for Devices and Radiological Health (CDRH), include the agency's rationale for the recommendations as well as the endorsement of the recommendations by several professional organizations. The final recommendations are being published in a pamphlet that is being made available to interested persons.
D004622:Embryo, Mammalian; D005260:Female; D005333:Fetus; D006748:Hospital Departments / Q000592:standards*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009682:Magnetic Resonance Spectroscopy / Q000592:standards*; D009684:Nuclear Medicine Department, Hospital / Q000592:standards*; D011247:Pregnancy; D011835:Radiation Protection / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration